Complete Story


Legislation to Increase PBM Transparency and Lower Out-of-Pocket Costs Introduced in Congress

February 14, 2023

Both chambers of the United States Congress are working on a top health care priority for the session—protecting patients from high out-of-pocket drug costs and pharmacy benefit manager (PBM) practices that could reduce access and adherence to treatments.

In the Senate, Senators Maria Cantwell (D-WA) and Chuck Grassley (R-IA) recently introduced the Pharmacy Benefit Manager Transparency Act of 2023 (S.127), legislation that would incentivize fair and transparent PBM practices, prohibit unfair or deceptive pricing practices, and mandate transparency. The Association for Clinical Oncology (ASCO) endorses is timely legislation and will continue to work with bill sponsors to shed light on opaque PBM practices that can negatively impact individuals with cancer.  READ MORE

Printer-Friendly Version